Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein
- 1 March 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 147 (5) , 516-523
Abstract
The present study attempted to pharmacologically characterize the muscarinic receptor subtypes mediating contraction of human umbilical vein (HUV). HUV rings were mounted in organ baths and concentration–response curves were constructed for acetylcholine (ACh) (pEC50: 6.16±0.04; maximum response 80.00±1.98% of the responses induced by serotonin 10 μM). The absence of endothelium did not modify the contractile responses of ACh in this tissue. The role of cholinesterases was evaluated: neither neostigmine (acetylcholinesterase inhibitor) nor iso‐OMPA (butyrylcholinesterase inhibitor) modified ACh responses. When both enzymes were simultaneously inhibited, a significantly but little potentiation was observed (control: pEC506.33±0.03; double inhibition: pEC506.57±0.05). Atropine, nonselective muscarinic receptors antagonist, inhibited ACh‐induced contraction (pKB9.67). The muscarinic receptors antagonists pirenzepine (M1), methoctramine (M2) and pFHHSiD (M3) also antagonized responses to ACh. The affinity values estimated for these antagonists against responses evoked by ACh were 7.58, 6.78 and 7.94, respectively. On the other hand, PD 102807 (M4selective muscarinic receptors antagonist) was ineffective against ACh‐induced contraction. In presence of a blocking concentration of pirenzepine, pFHHSiFD produced an additional antagonism activity on ACh‐induced responses. The M1muscarinic receptors agonist McN‐A‐343 produced similar maximum but less potent responses than ACh in HUV. The calculated pA2for pirenzepine against McN‐A‐343 induced responses was 8.54. In conclusion, the data obtained in this study demonstrate the role of M1muscarinic receptor subtypes and suggest the involvement of M3muscarinic receptor subtypes in ACh‐induced vasoconstriction in HUV rings. In addition, the vasomotor activity evoked by ACh does not seem to be modulated by endothelial factors, and their enzymatic degradation appears to have little functional relevance in this tissue. British Journal of Pharmacology(2006)147, 516–523. doi:10.1038/sj.bjp.0706654Keywords
This publication has 46 references indexed in Scilit:
- International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative PharmacologyPharmacological Reviews, 2003
- Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical veinBritish Journal of Pharmacology, 2003
- Muscarinic Receptor Subtypes Mediating Vasorelaxation of the Perforating Branch of the Human Internal Mammary ArteryPharmacology, 2001
- The Non-neuronal Cholinergic SystemThe Japanese Journal of Pharmacology, 2001
- Evidence for a M1 muscarinic receptor on the endothelium of human pulmonary veinsBritish Journal of Pharmacology, 2000
- Characterization of α1‐adrenoceptor subtypes mediating vasoconstriction in human umbilical veinBritish Journal of Pharmacology, 1999
- Pharmacological characterization of an α1A‐adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of ratBritish Journal of Pharmacology, 1997
- Expression of Muscarinic M sub 3 -Receptors Coupled to Inositol Phospholipid Hydrolysis in Human Detrusor Cultured Smooth Muscle CellsJournal of Urology, 1995
- Vasocontractile muscarinic M1 receptors in cat cerebral arteries: pharmacological identification and detection of mRNAEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Lack of innervation of human umbilical cord. An immunohistological and histochemical studyPlacenta, 1990